WeightWatchers New Logo 2023 - Sent to Globe for PR.PNG
WeightWatchers Announces Strategic Leadership Team Appointments
10 sept. 2024 09h06 HE | WW International Inc.
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today the appointments of Scott Honken as Chief Commercial Officer and...
Logo.png
iMD Companies, Inc. Subsidiary Riize, LLC to Expand Product Line With Contracted Telemedicine Doctors
04 sept. 2024 08h30 HE | iMD Companies, Inc.
New Products Include High Demand Hair Loss, Weight Loss, and Woman's Libido Products RANCHO CORDOVA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) has completed the...
U.S. Weight Loss Dietary Supplements Market
U.S. Weight Loss Dietary Supplements Market Insights Report 2024: A $3.66 Billion Market by 2029 - Shift Towards Natural & Herbal Ingredients, Gummies are Gaining Traction
29 août 2024 06h53 HE | Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Weight Loss Dietary Supplements Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. weight...
lemonaid-logo-color@4
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
28 août 2024 07h30 HE | 23andMe, Inc.
SUNNYVALE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., (Nasdaq: ME), and a leading telemedicine provider, is now offering Ozempic®, Wegovy®...
NexgenMD360
New Partnerships with Texas Family Fitness and UFC Gym Offer Members Exclusive Access to GLP-1 Weight Loss Programs
27 août 2024 09h13 HE | NexgenMD360
NexgenMD360's FDA-approved rapid weight loss programs using Semaglutide & Tirzepatide deliver 20%+ weight loss results for men and women nationwide.
ivyenrose_logo.png
Ivy En Rose MedSpa: San Francisco's Premier Destination for Elite Aesthetic Treatments
21 août 2024 10h00 HE | Ivy En Rose
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Ivy En Rose, one of San Francisco’s leading MedSpas, is proud to announce a series of cutting-edge services and luxurious treatments, cementing its...
Sesame, America’s Low-Cost Leader in Healthcare,  Makes Compounded Semaglutide Available to Eligible Patients “At Cost,” with no Retail Price Markup
Sesame, America’s Low-Cost Leader in Healthcare, Makes Compounded Semaglutide Available to Eligible Patients “At Cost,” with no Retail Price Markup
21 août 2024 09h00 HE | Sesame
NEW YORK CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced the launch of “Success by...
Logo_Diagnamed.png
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
15 août 2024 08h00 HE | DiagnaMed Holdings Corp.
TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
22157.jpg
China Weight Loss And Diet Products Competitive Landscape Report 2024
09 août 2024 04h51 HE | Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss And Diet Products Companies in China" report has been added to ResearchAndMarkets.com's offering.This study focuses on China's Weight Loss...
SNS-INSIDER-300X300.jpg
Weight Management Services Market to Reach USD 8.54 Billion By 2032, With a Growing CAGR of 6.95% | Research by SNS Insider
29 juil. 2024 13h40 HE | SNS Insider pvt ltd
Pune, July 29, 2024 (GLOBE NEWSWIRE) -- Weight Management Services Market Size Analysis: “According to SNS Insider Research, The Weight Management Services Market Size was valued at US$ 4.78...